Epigenetics
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, January 30, 2015

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, January 28, 2015

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

Pictured: Eytan Stein
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 11, 2014

An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

DNA wrapped around histones
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Pictured: Robin Roberts & Tonya Samuel
SUPPORT
By Maureen Salamon, BA, Freelance Writer  |  Friday, October 3, 2014

For people undergoing bone marrow or stem cell transplants, being isolated from friends, family, and everyday life can make recovery more difficult.

Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, September 25, 2014

Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital.

pictured: Martin S. Tallman
Profile
By Maureen Salamon, BA, Freelance Writer  |  Monday, May 19, 2014

Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

Pictured: José Baselga
Announcement
By Media Staff  |  Thursday, April 10, 2014

Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.

Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, February 20, 2014

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Pictured: Ellin Berman
Video
By Memorial Sloan Kettering  |  Friday, January 3, 2014

Oncologist and hematologist Ellin Berman describes how a team of experts provides a variety of therapeutic options to patients with leukemia, from standard of care treatments to new therapies available in clinical trials.

Pictured: T cells
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 23, 2013

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

Pictured: Ross Levine
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
In the News
By Christina Pernambuco-Holsten, MA, Managing Web Editor  |  Friday, December 6, 2013

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

Pictured: Farid Boulad
Cancer Guide
By Celia Gittelson, BA  |  Thursday, November 14, 2013

Memorial Sloan Kettering specialists provide state-of-the-art care for a range of pediatric blood disorders.

Pictured: Sergio Giralt & Robin Roberts
Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 17, 2013

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

Center News

Stay Informed

Get the latest information about cancer care and research every month.